Description:

Current data is presented with respect to the presence of controlled substance use among general practice patients, cost effective strategies for conducting a valid assessment, and crisis strategies for management, tapering, and interprofessional collaboration.

Objectives:

At the conclusion of this course, participants should be able to:

1. Be familiar with the current research findings associated with controlled substance risk assessment, particularly as they relate to opioid therapy.
2. Recognize particularly at-risk sub-groups, including populations utilizing controlled substances.
3. Review tools and techniques for assessing and managing the patient at risk.

Audience: All dental professionals

 Ronald J. Kulich, PhD has responsibilities including development and management of opioid risk assessment protocols for the Massachusetts General Hospital Pain Center and Facial Pain/Headache Center at Tufts School of Dental Medicine. Other academic responsibilities include treatment guideline development for work injury with specific focus on opioid therapy risk, Massachusetts Department of Industrial Accidents, membership in the Mass Pain Initiative Public Policy Council, and training committee for the MA Prescription Monitoring Program. Much of his recent work has been focused on CME/CE content development with respect to risk assessment for controlled substances. He has co-chaired the Massachusetts Dental Education Core Competencies Subcommittee for the Prevention and Management of Prescription Drug Misuse, and maintains membership in the Law Enforcement Prescription Monitoring Program Educational Program. His fellowship training responsibilities include supervision of Anesthesia/Pain Medicine and Orofacial Pain Medicine Fellows (Mass General Hospital), management of the behavioral sciences curriculum for Tufts School of Dental Medicine, and supervision of psychology graduate interns within the pain centers. Patient clinical care and assessment activities include evidence-based use of screening/assessment with a range of chronic pain populations, and impact of public policy on access to pain care. His work has resulted in over 100 publications. Most recent publications focus on questionnaire construction and outcome predictors with chronic opioid therapy.

Conflict of Interest: In accordance with ADA CERP Standard V, everyone involved in planning or presenting this educational activity will be required to disclose any relevant financial relationships with commercial interests. This information will be made available to participants at the start of the course.

Association for Continuing Dental Education (ACDE)

The ACDE, of which the University of Louisville School of Dentistry's Office of Continuing Education (ULSD CE) is a member, brings together individuals who represent university-based continuing dental education programs associated with accredited dental schools in Canada and the United States.

The ACDE and 35 of its member schools are jointly providing this series of live webinars featuring university-based key opinion leaders.

Each lecture will be presented by a different member school's faculty member. By registering through this page, ULSD CE will provide your verification of attendance document. Similar to our other CE offerings, we will maintain a record of your attendance in our database, which you may always access through your personal ULSD CE account.

CE staff of participating schools declare that neither they nor any member of their family have a financial arrangement or affiliation with any corporate organization offering financial support or grant monies for this continuing dental education program, nor do they have a financial interest in any commercial product(s) or service(s) the speaker will discuss in the presentation, within the last 12 months that are relevant to this educational activity.